Work

Differential TNFα and Toll-like-receptor 4-signaling in endocrine tumors after tumor-vascular-disrupting agent ASA404 (vadimezan) and TNFα treatment

Year: 2014

Type: article

Source: Experimental and Clinical Endocrinology & Diabetes

DOI: 10.1055/s-0034-1372034

Authors: C Hantel, R Lira, A Ozimek, R Frantsev, M Reincke, T Mussack, F Beuschlein

Institutions: Ludwig-Maximilians-Universität München, Universidade de São Paulo

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2804090467

FWCI:

Cites:

Cited by:

Related to: 10